Robert A. Cascella
Independent Chairman of the BoardMr. Robert A. Cascella, also known as Rob, is Chairman of the Board at Neuronetics, Inc. since May 27, 2021 and serves as Director since April 2021. He serves as Independent Director at Metabolon, Inc. since September 2020. Mr. Cascella retired from Royal Philips, a public Dutch multinational healthcare company, in 2021, where he served as Special Advisor and Strategic Business Development Leader. From April 2015 to April 2020, he served as Executive Vice President of Royal Philips and Chief Executive Officer of Philips' Diagnosis and Treatment businesses, including businesses serving Radiology, Cardiology and Oncology, as well as Enterprise Diagnostic Informatics. Mr. Cascella had been Executive Vice President of Koninklijke Philips N.V. from May 1, 2020 until April 1, 2021 and served as its Strategic Business Development Leader during the same period. He is Independent Director of KORU Medical Systems, Inc. (formerly known as Repro Med Systems, Inc.) since May 06, 2022. He serves as Independent Director at Mirion Technologies, Inc. since October 2021. He was Chief Business Leader of Precision Diagnosis of Koninklijke Philips N.V. since July 29, 2016. He also served as Chief Business Leader of Precision Diagnosis at Koninklijke Philips N.V. until May 1, 2020. He has served as the Chief Executive Officer of the Diagnostic Imaging Business Group at Koninklijke Philips N.V. from May 1, 2015 until July 29, 2016. Mr. Cascella served as Executive Vice President of Koninklijke Philips N.V. Mr. Cascella was a Partner of Carolina Financial Group. He served as an Advisor to Hologic, Inc. from July 18, 2013 to November 30, 2013. He served as the Chief Executive Officer of Hologic Inc. from November 5, 2009 to July 18, 2013 and served as its President from September 2003 to July 18, 2013. He served as an Associate Investment Banker at Capital Access LLC. Mr. Cascella served as the Chief Operating Officer at Hologic Inc. from February 2003 until December 2013. Mr. Cascella has senior management, operational and finance experience with companies ranging from early-stage, entrepreneurial businesses to Fortune 500 companies. He served as Managing Partner at CFG Capital, LLC from 1998 to 2003. He served as the Chief Operating Officer and Vice President of Finance at NeoVision Corp. from 1998 to 2003. Mr. Cascella played a principal role in the sale of NeoVision to U.S. Surgical Corporation in 1998 and assisted in transitioning its newly acquired business. Mr. Cascella has been an Independent Director of Celestica Inc. since February 1, 2019. He served in senior management roles at Perkin-Elmer Corporation. He served as the Healthcare Partner and Executive Council Member at CFG Capital, LLC, a boutique investment bank, from 1998 to 2003. From 1987 to 1994, he served as the President, Chief Operating Officer and Chief Financial Officer of Fischer Imaging Corp. He served as Director of Tegra Medical. He served as Chairman of the Board of DySIS Medical Ltd. from January 7, 2014 to October 11, 2016. He served as the Chairman and Member of the Strategic Advisory Board at Gamma Medica, Inc. since April 17, 2014. He served as a Director of DySIS Medical Ltd. since January 7, 2014. He served as a Director of Mirada Medical Limited. He served as a Director of Gen-Probe Incorporated from August 1, 2012. He served as a Director of Hologic Inc. from June 24, 2008 to July 18, 2013. Mr. Cascella holds a B.A. in accounting from Fairfield University.
Positions
- Company NameNeuronetics, Inc.Stock CodeSTIMPositionIndependent Chairman of the BoardColleagues
- DLDaniel L. ReuversCEO, President & Director
- RARobert A. CascellaIndependent Chairman of the Board
- NNNir NaorExecutive VP, CFO, Corporate Secretary, Principal Financial and Accounting Officer & Treasurer
- RGRobert GreeneSenior Vice President of Sales
- CSCory S. AndersonExecutive Vice President & General Manager of Greenbrook
- GPGlenn P. MuirIndependent Director
- SLSheryl L. ConleyIndependent Director
- MRMegan R. RosengartenIndependent Director
- Company NameMirion Technologies, Inc.Stock CodeMIRPositionIndependent DirectorColleagues
- TDThomas D. LoganFounder, Medical Group President, CEO & Chairman
- BSBrian SchopferCFO & Medical Group President
- ELEmmanuelle LeeExecutive VP, Chief Legal Officer, Chief Compliance Officer & Secretary
- AUAlison UlrichChief Human Resources Officer
- LELoic EloyGroup President of Nuclear & Safety Technologies
- SWSteven W. EtzelIndependent Director
- RARobert A. CascellaIndependent Director
- JWJohn W. KuoIndependent Director
- KCKenneth C. BockhorstLead Independent Director
- Company NameCelestica Inc.Stock CodeCLSPositionIndependent DirectorColleagues
- RARobert Andrew MionisCEO & Chair of the Board
- YLYann Louis EtienvreChief Operations Officer
- JPJason PhillipsAdvisor
- MCMandeep ChawlaGroup President of Global Markets
- TCTodd C. CooperPresident of Advanced Technology Solutions
- FCFrancoise ColpronIndependent Director
- AMAmar MaletiraIndependent Director
- LTLaurette T. KoellnerLead Independent Director
- Company NameKORU Medical Systems, Inc.Stock CodeKRMDPositionIndependent DirectorColleagues
- AKAdam KalbermattenPresident & CEO
- RJR. John FletcherIndependent Chairman of the Board
- TAThomas AdamsCFO, Secretary & Treasurer
- CPChristopher PazdanChief Operating Officer
- ESEric SchillerChief Technology Officer
- SMShahriar MatinIndependent Director
- RARobert A. CascellaIndependent Director
- JMJoseph Martin MankoLead Independent Director
- LMLinda M. TharbyDirector
